Does TACROLIMUS Cause Therapeutic response decreased? 187 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 187 reports of Therapeutic response decreased have been filed in association with TACROLIMUS (Tacrolimus). This represents 0.2% of all adverse event reports for TACROLIMUS.
187
Reports of Therapeutic response decreased with TACROLIMUS
0.2%
of all TACROLIMUS reports
18
Deaths
50
Hospitalizations
How Dangerous Is Therapeutic response decreased From TACROLIMUS?
Of the 187 reports, 18 (9.6%) resulted in death, 50 (26.7%) required hospitalization, and 7 (3.7%) were considered life-threatening.
Is Therapeutic response decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TACROLIMUS. However, 187 reports have been filed with the FAERS database.
What Other Side Effects Does TACROLIMUS Cause?
Off label use (8,718)
Drug ineffective (6,214)
Product use in unapproved indication (5,057)
Acute kidney injury (4,005)
Transplant rejection (3,526)
Cytomegalovirus infection (3,320)
Covid-19 (3,201)
Drug interaction (2,896)
Diarrhoea (2,854)
Toxicity to various agents (2,845)
What Other Drugs Cause Therapeutic response decreased?
DUPILUMAB (7,824)
ETANERCEPT (3,460)
ONABOTULINUMTOXINA (2,685)
METHOTREXATE (2,668)
INFLIXIMAB (1,991)
RITUXIMAB (1,728)
LEFLUNOMIDE (1,574)
TOCILIZUMAB (1,512)
HYDROXYCHLOROQUINE (1,485)
ADALIMUMAB (1,357)
Which TACROLIMUS Alternatives Have Lower Therapeutic response decreased Risk?
TACROLIMUS vs TACROLIMUS\TACROLIMUS ANHYDROUS
TACROLIMUS vs TADALAFIL
TACROLIMUS vs TAFAMIDIS
TACROLIMUS vs TAFAMIDIS MEGLUMINE
TACROLIMUS vs TAFASITAMAB